Lucioni C, Mazzi S, Caporali R. Budget impact analysis of infliximab biosimilar: the Italian scenery: Analisi di budget impact del biosimilare di infliximab: lo scenario italiano. Grhta [Internet]. 2015 Oct. 7 [cited 2024 Nov. 24];2(2):78-8. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/330